אימנד 150 מ"ג IV

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Tersedia dari:

MERCK SHARP & DOHME ISRAEL LTD

Kode ATC:

A04AD12

Bentuk farmasi:

POWDER FOR SOLUTION FOR INFUSION

Rute administrasi :

I.V

Diproduksi oleh:

MERCK SHARP & DOHME B.V, HOLLAND

Kelompok Terapi:

APREPITANT

Indikasi Terapi:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Tanggal Otorisasi:

2011-11-01